Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-23-051721
Filing Date
2023-02-28
Accepted
2023-02-27 21:54:27
Documents
56
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d425221d10k.htm   iXBRL 10-K 1472315
2 EX-31.1 d425221dex311.htm EX-31.1 11138
3 EX-31.2 d425221dex312.htm EX-31.2 11435
4 EX-32.1 d425221dex321.htm EX-32.1 5064
5 EX-32.2 d425221dex322.htm EX-32.2 5108
  Complete submission text file 0001193125-23-051721.txt   6216517

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ebac-20221231.xsd EX-101.SCH 58971
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ebac-20221231_cal.xml EX-101.CAL 22086
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ebac-20221231_def.xml EX-101.DEF 307412
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ebac-20221231_lab.xml EX-101.LAB 388714
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ebac-20221231_pre.xml EX-101.PRE 355981
50 EXTRACTED XBRL INSTANCE DOCUMENT d425221d10k_htm.xml XML 805399
Mailing Address EPFL INNOVATION PARK BUILDING LAUSANNE V8 1015
Business Address EPFL INNOVATION PARK BUILDING LAUSANNE V8 1015 41 77 976 21 09
European Biotech Acquisition Corp. (Filer) CIK: 0001841258 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40211 | Film No.: 23678117
SIC: 6770 Blank Checks